Correlation Between Recursion Pharmaceuticals and KEYBANK
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and KEYBANK NATL ASSN, you can compare the effects of market volatilities on Recursion Pharmaceuticals and KEYBANK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of KEYBANK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and KEYBANK.
Diversification Opportunities for Recursion Pharmaceuticals and KEYBANK
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Recursion and KEYBANK is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and KEYBANK NATL ASSN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KEYBANK NATL ASSN and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with KEYBANK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KEYBANK NATL ASSN has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and KEYBANK go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and KEYBANK
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 12.81 times more return on investment than KEYBANK. However, Recursion Pharmaceuticals is 12.81 times more volatile than KEYBANK NATL ASSN. It trades about 0.0 of its potential returns per unit of risk. KEYBANK NATL ASSN is currently generating about -0.12 per unit of risk. If you would invest 667.00 in Recursion Pharmaceuticals on September 21, 2024 and sell it today you would lose (63.00) from holding Recursion Pharmaceuticals or give up 9.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 56.25% |
Values | Daily Returns |
Recursion Pharmaceuticals vs. KEYBANK NATL ASSN
Performance |
Timeline |
Recursion Pharmaceuticals |
KEYBANK NATL ASSN |
Recursion Pharmaceuticals and KEYBANK Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Recursion Pharmaceuticals and KEYBANK
The main advantage of trading using opposite Recursion Pharmaceuticals and KEYBANK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, KEYBANK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KEYBANK will offset losses from the drop in KEYBANK's long position.Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
KEYBANK vs. Procter Gamble | KEYBANK vs. Unilever PLC ADR | KEYBANK vs. Sphere Entertainment Co | KEYBANK vs. NETGEAR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |